APA (7th ed.) Citation

McInnes, I., Higgs, R., Lee, J., Macias, W., Na, S., Ortmann, R., . . . Perrier, C. (2018). P059 Ex vivo comparison of baricitinib, upadacitinib, filgotinib and tofacitinib for cytokine signalling in human leukocyte subpopulations. Annals of the rheumatic diseases, 77(Suppl 1), A38. https://doi.org/10.1136/annrheumdis-2018-EWRR2018.78

Chicago Style (17th ed.) Citation

McInnes, IB, et al. "P059 Ex Vivo Comparison of Baricitinib, Upadacitinib, Filgotinib and Tofacitinib for Cytokine Signalling in Human Leukocyte Subpopulations." Annals of the Rheumatic Diseases 77, no. Suppl 1 (2018): A38. https://doi.org/10.1136/annrheumdis-2018-EWRR2018.78.

MLA (9th ed.) Citation

McInnes, IB, et al. "P059 Ex Vivo Comparison of Baricitinib, Upadacitinib, Filgotinib and Tofacitinib for Cytokine Signalling in Human Leukocyte Subpopulations." Annals of the Rheumatic Diseases, vol. 77, no. Suppl 1, 2018, p. A38, https://doi.org/10.1136/annrheumdis-2018-EWRR2018.78.